Allena Pharmaceuticals, Inc. (ALNA) declined in the Pre-market, here is why?
The stock of Allena Pharmaceuticals, Inc. (ALNA) slightly declined in the pre-market after the company announced its clinical and corporate update in a press release. The stock valued at around $0.51 in the pre-market. This is a loss of around 4.21% from the previously closed value. At the end of the last trading session, the […]